Mayo Clinic Q&A podcast: On the verge of predicted surge with COVID-19 delta variant
The delta variant is being blamed for hot spots in the U.S. where cases of COVID-19 are on the rise. These hot spots account for most cases in the U.S. They are also the geographical areas that tend to have the lowest vaccination rates.
"It's no surprise that the two go together," says Dr. Gregory Poland, an infectious diseases expert and head of Mayo Clinic's Vaccine Research Group.
"This (delta variant) is the bad actor that we predicted it would be," adds Dr. Poland. "Our seven-day average is getting up to 19,000 cases a day in the U.S. We were down to 3,000. So we're starting to see, just as we predicted, a surge as people took masks off and as restrictions were lifted before we had achieved high rates of immunization."
In this Mayo Clinic Q&A podcast, Dr. Poland expands on how the highly transmissible delta variant continues to spread. He also talks about the possibility of COVID-19 vaccine boosters, explains how the Vaccine Adverse Event Reporting System works, and much more as he answers listener questions.
___________________________________
Information in this post was accurate at the time of its posting. Due to the fluid nature of the COVID-19 pandemic, scientific understanding, along with guidelines and recommendations, may have changed since the original publication date.
For the safety of its patients, staff and visitors, Mayo Clinic has strict masking policies in place. Anyone shown without a mask was recorded prior to COVID-19 or recorded in an area not designated for patient care, where social distancing and other safety protocols were followed.
Dr. Poland has served as a consultant for Merck & Co. Inc., Medicago Inc., GlaxoSmithKline plc, Sanofi Pasteur, Emergent BioSolutions Inc., Dynavax Technologies Corp., Genentech Inc., Eli Lilly and Co., Janssen Pharmaceuticals Inc., Kentucky BioProcessing Inc. and Genevant Sciences Corp. Honoraria: Elsevier.
FOR THE PUBLIC: More health and medical news on the Mayo Clinic News Network. https://newsnetwork.mayoclinic.org/
FOR THE MEDIA ONLY: Register at https://newsnetwork.mayoclinic.org/re... to access clean and nat sound versions of this video on the Mayo Clinic News Network. https://newsnetwork.mayoclinic.org/
Mayo Clinic https://mayocl.in/3tNMAdF
Like Mayo Clinic on Facebook: https://www.facebook.com/
Follow Mayo Clinic on Twitter: https://twitter.com/MayoClinic
Видео Mayo Clinic Q&A podcast: On the verge of predicted surge with COVID-19 delta variant канала Mayo Clinic
"It's no surprise that the two go together," says Dr. Gregory Poland, an infectious diseases expert and head of Mayo Clinic's Vaccine Research Group.
"This (delta variant) is the bad actor that we predicted it would be," adds Dr. Poland. "Our seven-day average is getting up to 19,000 cases a day in the U.S. We were down to 3,000. So we're starting to see, just as we predicted, a surge as people took masks off and as restrictions were lifted before we had achieved high rates of immunization."
In this Mayo Clinic Q&A podcast, Dr. Poland expands on how the highly transmissible delta variant continues to spread. He also talks about the possibility of COVID-19 vaccine boosters, explains how the Vaccine Adverse Event Reporting System works, and much more as he answers listener questions.
___________________________________
Information in this post was accurate at the time of its posting. Due to the fluid nature of the COVID-19 pandemic, scientific understanding, along with guidelines and recommendations, may have changed since the original publication date.
For the safety of its patients, staff and visitors, Mayo Clinic has strict masking policies in place. Anyone shown without a mask was recorded prior to COVID-19 or recorded in an area not designated for patient care, where social distancing and other safety protocols were followed.
Dr. Poland has served as a consultant for Merck & Co. Inc., Medicago Inc., GlaxoSmithKline plc, Sanofi Pasteur, Emergent BioSolutions Inc., Dynavax Technologies Corp., Genentech Inc., Eli Lilly and Co., Janssen Pharmaceuticals Inc., Kentucky BioProcessing Inc. and Genevant Sciences Corp. Honoraria: Elsevier.
FOR THE PUBLIC: More health and medical news on the Mayo Clinic News Network. https://newsnetwork.mayoclinic.org/
FOR THE MEDIA ONLY: Register at https://newsnetwork.mayoclinic.org/re... to access clean and nat sound versions of this video on the Mayo Clinic News Network. https://newsnetwork.mayoclinic.org/
Mayo Clinic https://mayocl.in/3tNMAdF
Like Mayo Clinic on Facebook: https://www.facebook.com/
Follow Mayo Clinic on Twitter: https://twitter.com/MayoClinic
Видео Mayo Clinic Q&A podcast: On the verge of predicted surge with COVID-19 delta variant канала Mayo Clinic
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
A New Outlook for Amber-Rose - Mayo ClinicGregory Broderick, M.D. – Urology Residency Program DirectorMayo Clinic Minute: Coping with cancer-related fatigueMayo Clinic Minute: Burned Out NationIndividualized Medicine: Dustin's StoryPaige's Mayo Clinic Story: Synovial Cell SarcomaWhy Choose Mayo Clinic for Neurovascular CareMayo Clinic Minute: Decoding Food DatesNate Thompson - Mayo Clinic Sports MedicineElmo's Mayo Clinic Experience - Dilated Cardiomyopathy & Heart TransplantBreast Cancer - Wendy’s Mayo Clinic StoryAn "In your shoes" moment with Dr. Christopher CampThe Mayo Clinic Executive Health Program - George Robert's storyDr. Karen Newcomer - Cervical Spine Exam GuideMayo Clinic Minute - Visual snow2 years after face transplant, Andy Sandness' smile shows his progressBehind the scenes: Medical Laboratory ScientistMayo Clinic Minute: Can pushups predict your health?Shanna's Rotationplasty - Mayo ClinicMayo Clinic experts weigh in on gluten-free diets'She has big things ahead of her.' CAR-T cell therapy gives Florida teen hope